<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lu D</submitter><funding>Natural Science Foundation of Hubei Province</funding><funding>the PhD fellowship of Nanchang Hangkong University</funding><pagination>1749</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12480192</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The impact of tyrosine metabolism on the early diagnosis and treatment of breast cancer remains unclear. This underlines importance of exploring its mechanisms.&lt;h4>Methods&lt;/h4>This study conducted an integrated analysis of breast cancer transcriptome data from the TCGA and GEO databases, utilizing differential expression analysis, enrichment analysis, immune infiltration analysis, single-cell RNA sequencing analysis, hdWGCNA analysis, and molecular docking to investigate the role of tyrosine metabolism in breast cancer and its relationship with chemotherapy response.&lt;h4>Results&lt;/h4>The co-expression prognosis model of tyrosine metabolism developed in this study demonstrated superior performance in the prognostic assessment of breast cancer, achieving an AUC value of 0.73</pubmed_abstract><journal>Discover oncology</journal><pubmed_title>Deciphering key chemotherapeutic drug targets within tyrosine metabolism for breast cancer and advancing a wide-ranging diagnostic strategy.</pubmed_title><pmcid>PMC12480192</pmcid><funding_grant_id>2019CFB391</funding_grant_id><funding_grant_id>EA202008259</funding_grant_id><pubmed_authors>Shi HH</pubmed_authors><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Wu RM</pubmed_authors><pubmed_authors>Chen DJ</pubmed_authors><pubmed_authors>Lu D</pubmed_authors><pubmed_authors>Yi C</pubmed_authors><pubmed_authors>Cao SH</pubmed_authors><pubmed_authors>Jiang S</pubmed_authors><pubmed_authors>Xie ZL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Deciphering key chemotherapeutic drug targets within tyrosine metabolism for breast cancer and advancing a wide-ranging diagnostic strategy.</name><description>&lt;h4>Background&lt;/h4>The impact of tyrosine metabolism on the early diagnosis and treatment of breast cancer remains unclear. This underlines importance of exploring its mechanisms.&lt;h4>Methods&lt;/h4>This study conducted an integrated analysis of breast cancer transcriptome data from the TCGA and GEO databases, utilizing differential expression analysis, enrichment analysis, immune infiltration analysis, single-cell RNA sequencing analysis, hdWGCNA analysis, and molecular docking to investigate the role of tyrosine metabolism in breast cancer and its relationship with chemotherapy response.&lt;h4>Results&lt;/h4>The co-expression prognosis model of tyrosine metabolism developed in this study demonstrated superior performance in the prognostic assessment of breast cancer, achieving an AUC value of 0.73</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-07-15T09:48:06.721Z</modification><creation>2026-07-02T03:11:50.02Z</creation></dates><accession>S-EPMC12480192</accession><cross_references><pubmed>41021173</pubmed><doi>10.1007/s12672-025-03577-x</doi></cross_references></HashMap>